Once tumors had developed, as demonstrated by BLI, tumor-bearing mice received liposome SN-encapsulated L1CAM siRNA, negative control siRNA, or the SN vehicle alone intratumorally twice a week for 3 weeks, or else received no treatment (Fig. 7A). The gene discussed is L1CAM; the disease is neoplasm.